Leggett R W
Oak Ridge National Laboratory, TN 37831-6480, USA.
Health Phys. 1997 Oct;73(4):587-600. doi: 10.1097/00004032-199710000-00002.
The International Commission on Radiological Protection (ICRP) has adopted a new, age-specific biokinetic model for thorium, along with new assumptions concerning the fate of radioactive progeny produced in the body after intake of thorium. This paper explains the basis for the model and assumptions and examines some of their implications with regard to radiation dosimetry and bioassay. The new model differs substantially from the ICRP's previous biokinetic model for thorium (introduced in 1979 in ICRP Publication 30) with regard to model structure, sources of data used to derive parameter values, predictions of integrated activities of long-lived thorium isotopes in some radiosensitive organs, and predictions of the rates of urinary and fecal excretion of thorium at times remote from exposure. For the case of injection of 232Th into blood of an adult, the new model and assumptions yield 4- to 8-fold decreases in predictions of 50-y committed equivalent doses to radiosensitive skeletal tissues but 7- to 55-fold increases in predictions of committed equivalent doses to extra-skeletal tissues, compared with the model and treatment of decay chain members recommended in ICRP Publication 30.
国际放射防护委员会(ICRP)采用了一种新的、针对特定年龄的钍生物动力学模型,以及关于摄入钍后体内产生的放射性子代产物归宿的新假设。本文解释了该模型和假设的依据,并探讨了它们在辐射剂量学和生物测定方面的一些影响。新模型在模型结构、用于推导参数值的数据来源、某些放射敏感器官中长寿命钍同位素的累积活度预测以及远离暴露时间时钍的尿排泄率和粪排泄率预测等方面,与ICRP先前的钍生物动力学模型(1979年在ICRP第30号出版物中引入)有很大不同。对于向成年人体内血液注射232Th的情况,与ICRP第30号出版物中推荐的模型和衰变链成员处理方法相比,新模型和假设得出的对放射敏感骨骼组织的50年待积当量剂量预测降低了4至8倍,但对骨骼外组织的待积当量剂量预测增加了7至55倍。